Efficacy and adverse effects of cidofovir for treatment of BK virus infection in kidney transplant recipients
Kidney transplant provides patients with end-stage kidney disease a clear survival benefit compared to patients who remain on dialysis. Immunosuppressive therapy is crucial for maintaining graft survival. However, high level of suppression can increase the susceptibility for BK virus reactivation fo...
Main Authors: | Supavit Chesdachai, Charat Thongprayoon, Jackrapong Bruminhent, Wisit Cheungpasitporn |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Diabetic Nephropathy Prevention
2018-01-01
|
Series: | Journal of Nephropharmacology |
Subjects: | |
Online Access: | http://jnephropharmacology.com/PDF/npj-7-10.pdf |
Similar Items
-
Future directions in the treatment of BK virus
nephropathy
by: Wisit Cheungpasitporn, et al.
Published: (2018-01-01) -
Long-Term Outcome of Screening for Polyoma Bk Virus Infection in Kidney Transplant Recipients
by: Ziediņa Ieva, et al.
Published: (2013-04-01) -
Successful Treatment with Intravenous and Intravascular Cidofovir for BK Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
by: Azim Mehrvar, et al.
Published: (2021-06-01) -
High-level viruria as a screening tool for BK virus nephropathy in renal transplant recipients
by: W. James Chon, et al.
Published: (2016-09-01) -
Advances in BK Virus Complications in Organ Transplantation and Beyond
by: Abraham Cohen-Bucay, et al.
Published: (2020-11-01)